Cytex Technology Featured on Breakthroughs in Bioscience

Cytex’s 3-D weave technology is featured as this fall’s cover image on the Regenerative Medicine issue of Breakthroughs in Bioscience, a journal highlighting scientific breakthroughs important to society.  The publication is produced by Federation of American Societies for Experimental Biology (FASEB), the nation’s largest coalition of biomedical researchers.

Continue reading


Cytex accepted in NIH Commercialization Acceleration Program

Cytex is delighted to be awarded entry to the highly successful Commercialization Acceleration Program offered as a competitive award to recipients of NIH Phase II SBIR or STTR awards.  The program provides training and support for Cytex staff in commercialization activities such as regulatory planning, investment negotiations, and product marketing.

Continue reading


Cytex hip resurfacing technology featured in PNAS

Cytex’s VP of Research and Development, Dr. Brad Estes and Dr. Farsh Guilak, Professor of Orthopaedic Surgery at Washington University and Cytex’s President, co-led a team of researchers in a study published July 18, 2016 in the prestigious journal PNAS.  Results from this study highlighted Cytex’s tissue engineered implants’ cartilage-like properties, ability to maintain complex […]

Continue reading


Dr. Frank Moutos, Cytex VP of Technology Development, gives podium presentation at the Orthopaedic Research Society

The ORS hosts the premier orthopaedic research conference for basic science and clinical researchers in the United States.  Dr. Moutos presented findings from cutting-edge research in a talk entitled “Anatomically Shaped Tissue-Engineered Cartilage with Tunable and Inducible Anti-Cytokine Delivery for Biological Joint Resurfacing.”

Continue reading